ADURO BIOTECH INC's ticker is ADRO and the CUSIP is 00739L101. A total of 95 filers reported holding ADURO BIOTECH INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $6,000 | -14.3% | 2,645 | -23.2% | 0.00% | – |
| Q2 2020 | $7,000 | -46.2% | 3,445 | -31.2% | 0.00% | – |
| Q1 2020 | $13,000 | – | 5,009 | +4412.6% | 0.00% | – |
| Q4 2019 | $0 | -100.0% | 111 | -93.0% | 0.00% | – |
| Q2 2019 | $2,000 | -84.6% | 1,589 | -17.9% | 0.00% | – |
| Q2 2018 | $13,000 | -85.1% | 1,936 | -79.4% | 0.00% | -100.0% |
| Q1 2018 | $87,000 | +180.6% | 9,385 | +124.5% | 0.00% | +300.0% |
| Q4 2017 | $31,000 | +138.5% | 4,180 | +259.7% | 0.00% | 0.0% |
| Q4 2016 | $13,000 | -74.0% | 1,162 | -74.1% | 0.00% | -66.7% |
| Q2 2016 | $50,000 | -63.2% | 4,480 | -57.9% | 0.00% | -72.7% |
| Q1 2016 | $136,000 | +13500.0% | 10,648 | +11864.0% | 0.01% | – |
| Q3 2015 | $1,000 | 0.0% | 89 | +147.2% | 0.00% | – |
| Q2 2015 | $1,000 | – | 36 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 2,106,734 | $40,807,000 | 12.39% |
| Rock Springs Capital Management LP | 415,000 | $8,039,000 | 0.65% |
| CLOUGH CAPITAL PARTNERS L P | 592,697 | $11,481,000 | 0.50% |
| NJ State Employees Deferred Compensation Plan | 53,300 | $1,032,000 | 0.22% |
| Orbimed Advisors | 1,065,522 | $20,639,000 | 0.21% |
| Point72 Asset Management, L.P. | 845,700 | $16,381,000 | 0.13% |
| LMCG INVESTMENTS, LLC | 244,382 | $4,734,000 | 0.10% |
| EverPoint Asset Management, LLC | 150,000 | $2,906,000 | 0.08% |
| M&T BANK CORP | 566,560 | $10,974,000 | 0.08% |
| GLOBEFLEX CAPITAL L P | 15,200 | $294,000 | 0.06% |